Gentle ear vagus nerve stimulation to reduce headache after aneurysm stent coiling
Official title: Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Postoperative Headache Following Stent-Assisted Coiling of Unruptured Intracranial Aneurysms
Run by Beijing Tiantan Hospital · NCT07479082 · Data updated 2026-11-12
This study will try a noninvasive ear vagus nerve stimulation device to see if it reduces postoperative headaches in adults having stent-assisted coiling or flow-diverter treatment for unruptured brain aneurysms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 440 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | September 30, 2025 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT07479082 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 with imaging-confirmed unruptured intracranial aneurysms who are scheduled for stent-assisted coiling or flow-diverter embolization and can give informed consent are ideal candidates.
✕Probably not a fit
Patients with primary chronic headache disorders, prior seizures or vagotomy, implanted electronic devices, significant cardiac instability, skin lesions at the ear site, pregnancy, or other listed exclusions are not eligible and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–80 scheduled for stent-assisted coiling or flow-diverter embolization for unruptured intracranial aneurysms are randomized to receive active transcutaneous auricular vagus nerve stimulation (taVNS) or a sham placement. Participants begin wearing the device one day before the procedure and continue per protocol, with the active device placed on the left earlobe and the sham on the cymba conchae. The study compares incidence of headache within 90 days and use of analgesic medications between groups and monitors safety and tolerability. The trial is conducted at Capital Medical University Affiliated Beijing Tiantan Hospital as a single-center interventional study.
Why it matters
Potential benefit: If successful, taVNS could lower the frequency and severity of headache after aneurysm stent procedures and reduce the need for pain medications.
How similar studies have gone: Small pilot trials of taVNS have shown promise for some headache and pain conditions, but using taVNS specifically to prevent postoperative headache after aneurysm coiling is a relatively novel application with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-80 years 2. Diagnosed with unruptured intracranial aneurysm confirmed by imaging 3. Planned to undergo stent-assisted coiling or flow diverter embolization 4. Signed informed consent Exclusion Criteria: 1. History of SAH, ICH, brain tumor, major trauma, substance abuse, syncope, or seizures 2. Recurrent/traumatic/infectious/myxomatous aneurysms 3. Primary headache disorders (e.g., migraine, cluster headache, trigeminal neuralgia) not attributed to UIA 4. Previous vagotomy, migraine surgery, or implanted neurostimulators 5. Other concurrent electronic/implantable devices (e.g., pacemakers, neurostimulators) 6. Clinically significant hypotension, congenital heart disease, severe arrhythmia, unstable angina, or recent MI 7. Inability to follow up due to severe psychiatric disorder or refusal 8. Skin lesions at taVNS placement site 9. Pregnant or lactating 10. Participation in other trials
Where it's running
-
Capital Medical University Affiliated Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Qingyuan Liu, M.D.
- Email: 13260457220@163.com
- Phone: +86-13260457220
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting unruptured brain aneurysm rupture risk with blood pressure variability and 3D changes
This study follows adults with unruptured intracranial aneurysms who are managed without surgery to see if blood pressure variability and 3D changes in the aneurysm can predict rupture risk using advanced AI.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
Early complications after flow diverter versus stent-assisted coiling for unruptured wide-neck intracranial bifurcation aneurysms
This real-world study tests which endovascular treatment—flow diverter or stent-assisted coiling—has fewer early complications in adults with unruptured wide-neck bifurcation aneurysms.
-
Immediate neck manual therapy effects on atlas position and neck muscles
This trial tests two upper neck manual therapy techniques to see their immediate effect on neck alignment, atlas position, and a neck muscle shape in adults with head and neck pain or headaches.
-
Vitamin IV lidocaine before fundal pressure to prevent headache after cesarean using spinal anesthesia
This trial tests whether a single intravenous dose of lidocaine given before fundal pressure during cesarean delivery reduces the chance or severity of headache.
-
Muscle Position and Dry Needling Efficacy
This study tests whether the position of the upper trapezius during dry needling changes pain and function for people with chronic neck pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.